HOME / People

people

Shatha Boukeileh

Shatha Boukeileh

Shatha Boukeileh is a first year Ph.D. student in Pharmacology at the Hebrew University of Jerusalem, under the supervision of Prof. Francesca Levi Shaffer and Prof. Boaz Tirosh.
Her doctoral research investigates the interconnectivity of KIT signaling and the unfolded protein response in normal and neoplastic mast cell function and survival, which may allow to implement pharmacological agents to control mast cells driven diseases
​​​​​​​Shatha obtained her B.Sc. degree in Pharmacy in 2010 form the University of Jordan and M.Sc. In Pharmaceutical Science from the Hebrew University of Jerusalem in  2014.
Reem Ghadir

Reem Ghadir

I was born and raised in Bir el-Maksur in the lower Galilee.
I am a first year student in the direct track towards Ph.D in Chemistry.
My research is exploring protein folding using chemical protein synthesis tools under the supervision of Prof. Norman Metanis, in the institute of Chemistry at the Hebrew University.
The goal is to obtain a deep understanding of protein features and functionality.
I completed my B.Sc. in chemical and biological sciences in the Hebrew University.
Shrouq Mujahed

Shrouq Mujahed

My name is Shrouq Mujahed, I was born and raised in Jerusalem. I obtained my B.Sc from Birzeit University and my Masters degree from the Hebrew university of Jerusalem.
I am currently continuing my PhD at the faculty of Chemistry, also at the Hebrew University of Jerusalem. I am working under the supervision of Prof. Dmitri Gelman, in which our area of focus is to develop and design new three-dimensional PCP pincer com
The importance of these catalysts lies on their ability of producing molecular Hydrogen (energy) form either natural or artificial feedstock in an efficient and a controllable sense.
Reem Sbieh

Reem Sbieh

My name is Reem Sbieh. I'm a first year PhD student at the Hebrew University of Jerusalem.
In my lab we study the relationship between cancer and the immune system.
My project involves deciphering regulatory networks that govern cytotoxic T cells' dysfunction, which will hopefully aid in future development of efficient immunotherapies for various types o f cancer.